Twin Tree Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-15,923
| Closed | -$1.61M | – | 1626 |
|
|
2025
Q1 | $1.61M | Sell |
15,923
-112,153
| -88% | -$11.3M | ﹤0.01% | 1188 |
|
|
2024
Q4 | $11.4M | Sell |
128,076
-79,930
| -38% | -$7.04M | 0.02% | 644 |
|
|
2024
Q3 | $17.4M | Buy |
208,006
+87,419
| +72% | +$6.89M | 0.03% | 464 |
|
|
2024
Q2 | $9.29M | Buy |
+120,587
| New | +$8.83M | 0.02% | 591 |
|
|
2023
Q4 | – | Sell |
-33,590
| Closed | -$1.79M | – | 1376 |
|
|
2023
Q3 | $1.77M | Sell |
33,590
-301,717
| -90% | -$15.8M | ﹤0.01% | 893 |
|
|
2023
Q2 | $18.1M | Buy |
+335,307
| New | +$17.5M | 0.03% | 446 |
|
|
2022
Q3 | – | Sell |
-40,953
| Closed | -$1.64M | – | 1334 |
|
|
2022
Q2 | $1.53M | Buy |
+40,953
| New | +$1.67M | ﹤0.01% | 1135 |
|
|
2022
Q1 | – | Sell |
-11,679
| Closed | -$506K | – | 1637 |
|
|
2021
Q4 | $496K | Buy |
+11,679
| New | +$491K | ﹤0.01% | 1338 |
|
|
2021
Q2 | – | Sell |
-9,804
| Closed | -$379K | – | 1346 |
|
|
2021
Q1 | $379K | Sell |
9,804
-220,224
| -96% | -$8.34M | ﹤0.01% | 1095 |
|
|
2020
Q4 | $8.27M | Buy |
230,028
+96,285
| +72% | +$3.47M | 0.03% | 492 |
|
|
2020
Q3 | $5.11M | Sell |
133,743
-227,664
| -63% | -$8.77M | 0.02% | 566 |
|
|
2020
Q2 | $12.7M | Buy |
361,407
+187,366
| +108% | +$6.75M | 0.05% | 396 |
|
|
2020
Q1 | $5.68M | Buy |
174,041
+107,855
| +163% | +$4.21M | 0.03% | 453 |
|
|
2019
Q4 | $2.99M | Buy |
66,186
+16,623
| +34% | +$696K | 0.01% | 623 |
|
|
2019
Q3 | $2.02M | Sell |
49,563
-164,285
| -77% | -$6.96M | 0.01% | 682 |
|
|
2019
Q2 | $9.19M | Buy |
213,848
+204,460
| +2,178% | +$7.86M | 0.04% | 321 |
|
|
2019
Q1 | $360K | Sell |
9,388
-63,671
| -87% | -$2.43M | ﹤0.01% | 988 |
|
|
2018
Q4 | $2.58M | Sell |
73,059
-60,645
| -45% | -$2.2M | 0.02% | 664 |
|
|
2018
Q3 | $5.15M | Sell |
133,704
-78,149
| -37% | -$2.73M | 0.04% | 390 |
|
|
2018
Q2 | $6.93M | Sell |
211,853
-20,849
| -9% | -$629K | 0.04% | 343 |
|
|
2018
Q1 | $6.36M | Buy |
+232,702
| New | +$6.32M | 0.05% | 295 |
|
|
2017
Q3 | – | Sell |
-116,728
| Closed | -$3.24M | – | 986 |
|
|
2017
Q2 | $3.24M | Buy |
116,728
+20,452
| +21% | +$543K | 0.03% | 466 |
|
|
2017
Q1 | $2.39M | Buy |
+96,276
| New | +$2.34M | 0.02% | 518 |
|
|
2016
Q4 | – | Sell |
-44,131
| Closed | -$1.05M | – | 1168 |
|
|
2016
Q3 | $1.05M | Sell |
44,131
-13,522
| -23% | -$323K | 0.01% | 661 |
|
|
2016
Q2 | $1.35M | Buy |
57,653
+233
| +0.4% | +$5.04K | 0.02% | 574 |
|
|
2016
Q1 | $1.08M | Buy |
57,420
+49,452
| +621% | +$869K | 0.02% | 586 |
|
|
2015
Q4 | $147K | Buy |
+7,968
| New | +$143K | ﹤0.01% | 1144 |
|
|
2015
Q3 | – | Sell |
-10,660
| Closed | -$182K | – | 1322 |
|
|
2015
Q2 | $189K | Sell |
10,660
-42,179
| -80% | -$754K | ﹤0.01% | 1076 |
|
|
2015
Q1 | $938K | Buy |
+52,839
| New | +$835K | 0.02% | 602 |
|
|
2014
Q3 | – | Sell |
-271
| Closed | -$3K | – | 993 |
|
|
2014
Q2 | $3K | Sell |
271
-32,220
| -99% | -$419K | ﹤0.01% | 879 |
|
|
2014
Q1 | $439K | Sell |
32,491
-19,714
| -38% | -$259K | 0.01% | 771 |
|
|
2013
Q4 | $628K | Buy |
52,205
+8,641
| +20% | +$102K | 0.02% | 700 |
|
|
2013
Q3 | $511K | Buy |
+43,564
| New | +$471K | 0.02% | 597 |
|
Other funds holding BSX
Twin Tree Management's BSX Position: Q2 2025 in Review
Twin Tree Management sold out of Boston Scientific (BSX) in Q2 2025, closing a stake of 15,923 shares — an estimated $1.61M sold.
Twin Tree Management first reported a position in BSX in Q3 2013 and held it in 33 quarters. The position peaked at $18.1M in Q2 2023. 1,693 funds tracked by Wall St. Rank hold BSX as of Q2 2025.
- Twin Tree Management reported no remaining Boston Scientific position as of Q2 2025 after selling out during the quarter.
- Twin Tree Management sold 15,923 Boston Scientific shares in Q2 2025, an estimated $1.61M.
- Twin Tree Management first reported a position in Boston Scientific in Q3 2013 and held it in 33 quarters.
- Twin Tree Management's Boston Scientific position peaked at $18.1M in Q2 2023.
- 1,693 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2025.
Based on Twin Tree Management's 13F filing for Q2 2025, filed 28 Jul 2025.